Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.
Lalitha Krishna Shankar, John M. Hoffman, S.L. Bacharach et al. · PubMed · 2006
Many therapeutic clinical trials have proposed using a measure of metabolic change to assess therapeutic response rather than relying on conventional anatomic measurements of changes in tumor size on CT or MRI. PET assessment of changes in 18F-FDG uptake by tumors is gaining accep-tance as such a measure. Despite the increasing use of 18F-FDG PET as a bio-marker for predicting therapeutic response, there are no widely accepted standardized protocols for using 18F-FDG PET as a tool for assessing response to therapy, nor are there validated criteria for judging response using 18F-FDG PET. The European PET community, working with the European Organization for Research and Treatment of Can-cer, initiated a project to begin defining response criteria for PET and published their preliminary consensus recommen-
Cited by 678 works.
Authors
- Lalitha Krishna Shankar
- John M. Hoffman
- S.L. Bacharach
- Michael M. Graham
- Joel S. Karp
- Adriaan A. Lammertsma
- Steven M. Larson
- David A. Mankoff
- Barry Alan Siegel
- Annick Van den Abbeele
- Jeffrey T. Yap
References
- Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
- THE METABOLISM OF TUMORS
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations
- Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations
- Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study.
- Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake.
- Reproducibility of metabolic measurements in malignant tumors using FDG PET.
- Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.
- Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry.
- Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography.